Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 ...
The pharmaceutical company expects the expansion will create thousands of jobs.
Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...
Eli Lilly plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the drugmaker said at a ...
Eli Lilly wants the most optimal locations to host its new manufacturing facilities in the U.S.—and it’s open to pitche | Eli ...
With this latest announcement, Lilly has committed to investing more than $50 billion in U.S. manufacturing since 2020.
Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...
The move comes after President Donald Trump warned Big Pharma leaders that he would impose tariffs on them if they refuse to ...
Eli Lilly has unveiled plans to invest at least $27bn in building four new pharmaceutical manufacturing sites in the US.
Eli Lilly is doubling its U.S. manufacturing investment since 2020 as it seeks to produce more drugs domestically. Its latest ...
Eli Lilly (NYSE:LLY) recently announced its plans to invest $27 billion in four new U.S. manufacturing plants over the next five years, creating thousands of jobs. This move comes at a time when ...
Eli Lilly plans to invest $27 billion in new U.S. plants amidst threats of drug import tariffs by the Trump administration.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results